CC
ABBV icon

Coastland Capital’s AbbVie ABBV Stock Holding History

Coastland Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-58,000
Closed -$3.9M – 188
2015
Q2 		$3.9M Hold
58,000
– – 0.11% 149
2015
Q1 		$3.4M Buy
+58,000
New +$3.5M 0.11% 120

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Coastland Capital's ABBV Position: Q3 2016 in Review

Coastland Capital sold out of AbbVie (ABBV) in Q3 2016, closing a stake of 125,000 shares — an estimated $7.74M sold.

Coastland Capital first reported a position in ABBV in Q2 2016 and held it in 1 quarter. The position peaked at $7.74M in Q2 2016. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

  • Coastland Capital reported no remaining AbbVie position as of Q3 2016 after selling out during the quarter.
  • Coastland Capital sold 125,000 AbbVie shares in Q3 2016, an estimated $7.74M.
  • Coastland Capital first reported a position in AbbVie in Q2 2016 and held it in 1 quarter.
  • Coastland Capital's AbbVie position peaked at $7.74M in Q2 2016.
  • 1,653 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Coastland Capital's 13F filing for Q3 2016, filed 14 Nov 2016.